애브비(주)
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionGriffin Asset Management, Inc.
Latest Disclosed Ownership78,725 shares
Latest Disclosed Value $ 17,121,841
Griffin Asset Management, Inc. reports 2.72% decrease in ownership of ABBV / AbbVie Inc.

On April 30, 2026 - Griffin Asset Management, Inc. filed a 13F-HR form disclosing ownership of 78,725 shares of AbbVie Inc. (MX:ABBV) valued at $17,121,841 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 80,929 shares of AbbVie Inc.. This represents a change in shares of -2.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F ABBVIE COM 00287Y109 78,725 -2,204 -2.72 17,122 -7.41 1.9312
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 80,929 734 0.92 18,491 -0.41 2.0007
2025-10-16 2025-09-30 13F ABBVIE COM 00287Y109 80,195 60 0.07 18,568 24.84 2.0864
2025-07-25 2025-06-30 13F ABBVIE COM 00287Y109 80,135 -1,411 -1.73 14,875 -12.94 1.7565
2025-04-16 2025-03-31 13F ABBVIE COM 00287Y109 81,546 -110 -0.13 17,086 17.75 2.0916
2025-01-22 2024-12-31 13F ABBVIE COM 00287Y109 81,656 1,074 1.33 14,510 -8.82 1.7050
2024-10-15 2024-09-30 13F ABBVIE COM 00287Y109 80,582 -2,946 -3.53 15,913 11.08 1.7800
2024-07-23 2024-06-30 13F ABBVIE COM 00287Y109 83,528 74 0.09 14,327 -5.73 1.6596
2024-04-17 2024-03-31 13F ABBVIE COM 00287Y109 83,454 -5,896 -6.60 15,197 9.76 1.8124
2024-01-19 2023-12-31 13F ABBVIE COM 00287Y109 89,350 -193 -0.22 13,847 3.74 1.7558
2023-10-19 2023-09-30 13F ABBVIE COM 00287Y109 89,543 20 0.02 13,347 10.66 1.8970
2023-08-01 2023-06-30 13F ABBVIE COM 00287Y109 89,523 1,526 1.73 12,061 -14.00 1.6327
2023-05-09 2023-03-31 13F ABBVIE COM 00287Y109 87,997 -823 -0.93 14,024 -2.30 1.9595
2023-01-20 2022-12-31 13F ABBVIE COM 00287Y109 88,820 2,551 2.96 14,354 23.98 2.1646
2022-10-19 2022-09-30 13F ABBVIE COM 00287Y109 86,269 -431 -0.50 11,578 -12.81 1.9235
2022-07-19 2022-06-30 13F ABBVIE COM 00287Y109 86,700 -7,643 -8.10 13,279 -13.18 2.1188
2022-04-12 2022-03-31 13F ABBVIE COM 00287Y109 94,343 -14,063 -12.97 15,294 4.20 1.9816
2022-01-28 2021-12-31 13F ABBVIE COM 00287Y109 108,406 4,965 4.80 14,678 31.55 1.8231
2021-11-05 2021-09-30 13F ABBVIE COM 00287Y109 103,441 -4,600 -4.26 11,158 -8.32 1.4271
2021-07-28 2021-06-30 13F AbbVie COM 00287Y109 108,041 202 0.19 12,170 4.28 1.4671
2021-05-04 2021-03-31 13F AbbVie COM 00287Y109 107,839 2,063 1.95 11,670 2.96 1.4918
2021-01-27 2020-12-31 13F AbbVie COM 00287Y109 105,776 4,946 4.91 11,334 28.33 1.5029
2020-11-12 2020-09-30 13F AbbVie COM 00287Y109 100,830 -20,803 -17.10 8,832 -26.04 1.3580
2020-08-18 2020-06-30 13F AbbVie COM 00287Y109 121,633 4,775 4.09 11,942 34.13 1.9104
2020-05-18 2020-03-31 13F AbbVie COM 00287Y109 116,858 40 0.03 8,903 -13.92 1.6860
2020-02-11 2019-12-31 13F AbbVie COM 00287Y109 116,818 659 0.57 10,343 17.59 1.4499
2019-11-05 2019-09-30 13F AbbVie COM 00287Y109 116,159 649 0.56 8,796 4.71 1.3661
2019-08-19 2019-06-30 13F AbbVie COM 00287Y109 115,510 1,976 1.74 8,400 -8.20 1.0689
2019-05-08 2019-03-31 13F AbbVie COM 00287Y109 113,534 -16,189 -12.48 9,150 -23.49 1.2942
2019-03-01 2018-12-31 13F AbbVie COM 00287Y109 129,723 5,816 4.69 11,959 2.05 2.0183
2018-11-19 2018-09-30 13F AbbVie COM 00287Y109 123,907 1,143 0.93 11,719 3.03 1.7247
2018-08-15 2018-06-30 13F AbbVie COM 00287Y109 122,764 -2,030 -1.63 11,374 -3.71 2.0638
2018-05-16 2018-03-31 13F AbbVie COM 00287Y109 124,794 -3,824 -2.97 11,812 -5.04 2.1498
2018-02-20 2017-12-31 13F AbbVie COM 00287Y109 128,618 -20,289 -13.63 12,439 -5.99 2.2135
2017-11-15 2017-09-30 13F AbbVie COM 00287Y109 148,907 23,128 18.39 13,232 45.09 2.3893
2017-08-29 2017-06-30 13F AbbVie COM 00287Y109 125,779 -585 -0.46 9,120 21.83 2.4378
2016-02-17 2015-12-31 13F AbbVie COM 00287Y109 126,364 -4,330 -3.31 7,486 5.27 3.1482
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 130,694 -1,517 -1.15 7,111 -19.95 2.9573
2015-08-05 2015-06-30 13F AbbVie COM 00287Y109 132,211 -4,422 -3.24 8,883 11.05 3.4085
2015-04-27 2015-03-31 13F AbbVie COM 00287Y109 136,633 7,297 5.64 7,999 -5.49 2.3224
2015-01-12 2014-12-31 13F AbbVie COM 00287Y109 129,336 -4,016 -3.01 8,464 9.89 2.2496
2014-11-03 2014-09-30 13F AbbVie COM 00287Y109 133,352 -9,329 -6.54 7,702 -4.36 2.2990
2014-08-06 2014-06-30 13F AbbVie COM 00287Y109 142,681 7,517 5.56 8,053 15.92 2.5185
2014-04-14 2014-03-31 13F AbbVie COM 00287Y109 135,164 1,128 0.84 6,947 -1.85 2.2538
2014-01-29 2013-12-31 13F AbbVie COM 00287Y109 134,036 10,007 8.07 7,078 27.58 2.2874
2013-11-01 2013-09-30 13F AbbVie COM 00287Y109 124,029 1,022 0.83 5,548 9.11 1.8123
2013-08-21 2013-06-30 13F AbbVie COM 00287Y109 123,007 123,007 5,085 1.8397
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.